Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com    Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts    Investorideas.com crypto corner    Play by Play – the latest sports headlines and sports stock news

 

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; TSXV: $GENE.V, TSXV: $META.V, CSE: $CHV.C

July 20th Potcast sponsored by Lexaria Bioscience Corp. (CSE: $LXX.C) (OTC: $LXRP) a #Cannabis company with a new disruptive drug delivery platform: DehydraTECH

Investorideas.com podcasts

 

Pt. Roberts, WA; Delta, BC - July 20, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its "potcast' site, www.potcasts.ca release today's edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

http://www.investorideas.com/Audio/Podcasts/2018/072018-StocksToWatch.mp3

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: GENE, TSXV: META, CSE: CHV

Today's podcast overview/transcript:

Good morning and welcome to another Investorideas.com potcast ; looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today's potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on the OTC as LXRP. Lexaria has developed a new disruptive drug delivery platform: DehydraTECH The Company's patented technology changes the way Active Pharmaceutical Ingredients ("APIs") enter the body orally:

1) Masks unwanted tastes - eliminates the need for sugar-filled edibles.

2) Reduces time of onset - effects are felt within 15-20 min vs. 60-120 min.

3) Avoids first-pass liver metabolism

4) Increases bio-absorption by 5-10X

The Company's DehydraTECH™ technology is patent-protected for multiple APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble vitamins.

Learn more about Lexaria at www.lexariabioscience.com

Today's podcast features news announcements from INVICTUS MD STRATEGIES CORP. trading (TSX-Venture GENE and OTC: IVITF) , National Access Cannabis Corp. ( TSX-VENTURE: META) and Canada House Wellness Group Inc. (CSE: CHV) .

INVICTUS MD STRATEGIES CORP. announced that it has entered into a binding letter of intent ("LOI") to acquire 100% of the issued and outstanding shares of a medical clinic and cannabis retail company ("Clinic and Retail Co") that operates medical clinics in, Alberta, and is awaiting final review and approval for a retail cannabis license from the Alberta Gaming and Liquor Commission ("AGLC).

The medical clinics' patient-first business model features educators and physicians on-site to educate patients about medical cannabis and how to access it safely in Canada. In four easy steps, patients can see a physician, access educational support, and register with a licensed producer to begin receiving product. The cannabis clinic has 3,400 patients registered under Access to Cannabis for Medical Purposes Regulations ("ACMPR"), providing a direct channel to Invictus owned Licensed Producers ("LPs"), fully licensed under ACMPR.

National Access Cannabis Corp. today announced that it has entered into a loan agreement and connected collateral documents with Opaskwayak Cree Nation ("OCN") in respect of a secured loan, pursuant to which OCN will lend up to $35,000,000 to NAC. The Company plans to use the proceeds from the Loan to build-out up to 50-70 cannabis retail locations across Western Canada in 2018 under NAC's retail brand Meta Cannabis Supply Co.™ ("META"), as well as for working capital purposes. META stores are currently under construction in Manitoba.

The Board of Directors of Canada House Wellness Group Inc. announced today the hiring of Alex Kroon as Executive Vice-President of the Company and President of the Company's wholly owned subsidiary Marijuana for Trauma ("MFT") as well as the hiring of Steven Pearce as Vice-President, Legal. Alex Kroon's start date is August 13th, 2018 and Steven Pearce is starting immediately. Both Steven and Alex will be part of the Canada House executive council. Michael Southwell, MFT's Vice-President from 2013-2017 and President from 2017-2018 will resign as President of MFT effective August 13th, 2018 but will continue as a valued and important member of Canada House's leadership team in his capacity as a member of the Board. The Board would also like to thank Riley McGee for his efforts over the past year in the management of MFT.

MFT was founded by Fabian Henry and Mike Southwell in 2013 and has grown under their direction to one of Canada's leading cannabinoid therapy companies, with 11 clinics spanning six provinces providing leading treatment plans and support to a variety of medical patients, including military veterans, first responders, law enforcement, and civilians with, among other conditions, PTSD.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas potcasts

Subscribe to the new cannabis podcast series:

http://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit http://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.

Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp

To sponsor this podcast or be a guest

Contact Investorideas.com

http://www.investorideas.com/About/Contact.asp

800-665-0411


Do you trade or invest in Marijuana / Hemp Stocks? Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks

Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing